These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

841 related items for PubMed ID: 8227362

  • 21. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA, Lagarde M, Venton DL, Le Breton GC.
    J Biol Chem; 1992 Apr 05; 267(10):6541-7. PubMed ID: 1532390
    [Abstract] [Full Text] [Related]

  • 22. Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.
    Brass LF, Shaller CC, Belmonte EJ.
    J Clin Invest; 1987 Apr 05; 79(4):1269-75. PubMed ID: 3031135
    [Abstract] [Full Text] [Related]

  • 23. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE, Burch RM, Saussy DL, Kochel PJ, Halushka PV.
    J Pharmacol Exp Ther; 1985 Dec 05; 235(3):729-34. PubMed ID: 3001275
    [Abstract] [Full Text] [Related]

  • 24. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
    Murray R, Shipp E, FitzGerald GA.
    J Biol Chem; 1990 Dec 15; 265(35):21670-5. PubMed ID: 1701435
    [Abstract] [Full Text] [Related]

  • 25. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 01; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR.
    Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894
    [Abstract] [Full Text] [Related]

  • 30. Impaired signal transduction in neonatal platelets.
    Israels SJ, Cheang T, Roberston C, McMillan-Ward EM, McNicol A.
    Pediatr Res; 1999 May 01; 45(5 Pt 1):687-91. PubMed ID: 10231866
    [Abstract] [Full Text] [Related]

  • 31. Regulation of thromboxane receptor activation in human platelets.
    Murray R, FitzGerald GA.
    Proc Natl Acad Sci U S A; 1989 Jan 01; 86(1):124-8. PubMed ID: 2521385
    [Abstract] [Full Text] [Related]

  • 32. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R, Mezzasoma AM, Venditti G, Gresele P.
    Thromb Haemost; 2002 Jan 01; 87(1):114-21. PubMed ID: 11848439
    [Abstract] [Full Text] [Related]

  • 33. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
    Nakano T, Hanasaki K, Arita H.
    J Biol Chem; 1989 Apr 05; 264(10):5400-6. PubMed ID: 2494164
    [Abstract] [Full Text] [Related]

  • 34. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
    Mais DE, Liel N, Halushka PV.
    Biochem Pharmacol; 1990 Oct 01; 40(7):1457-61. PubMed ID: 2145838
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM, Pignatelli P, Riondino S, Parisi S, Castiglioni C, Gazzaniga PP.
    Thromb Res; 1994 Jun 01; 74(5):453-61. PubMed ID: 8085246
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets.
    Liel N, Mais DE, Halushka PV.
    Prostaglandins; 1987 Jun 01; 33(6):789-97. PubMed ID: 2959986
    [Abstract] [Full Text] [Related]

  • 40. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.